The manufacturer was previously received information alleging an issue related to a cpap device's sound abatement foam.There was no report of patient harm or injury.In the previously submitted report section b5 was incomplete, section b5 is- the patient also alleged visualization of particles and having headaches, nausea, vertigo, eye irritation, red and swollen skin on face, heavy chest, increased shortness of breath, worsened afib, heart ablation.The device was returned to the manufacturer's product investigation laboratory for investigation.An internal visual inspection of the device was completed by the manufacturer.The manufacturer found evidence of fine black hair like contamination on exterior of iso port, fine white dust like and short hair like contamination on blower, circular marring of interior surface of blower box lid, fine black dust like contamination consistent with keratin around blower seal, fluid ingress and mineral deposits on blower and in blower box.The manufacturer found no evidence of sound abatement foam degradation/breakdown.The device was hooked up to power supply, airflow was verified and the device operated properly.The device's event logs were downloaded and reviewed.The manufacturer found no errors logged.The manufacturer concludes there was evidence of fine black hair like contamination on exterior of iso port, fine white dust like and short hair like contamination on blower, circular marring of interior surface of blower box lid, fine black dust like contamination consistent with keratin around blower seal, fluid ingress and mineral deposits on blower and in blower box.The manufacturer confirmed there was no evidence of sound abatement foam degradation/breakdown.
|